Medtronic CoreValve Evolut

The Medtronic CoreValve and its successor, the Evolut series, are pioneering medical devices designed for Transcatheter Aortic Valve Replacement (TAVR). This technology allows for the replacement of a diseased aortic valve through a minimally invasive catheter-based procedure rather than open-heart surgery. The valve structure consists of a self-expanding nitinol frame and porcine pericardial tissue leaflets.

Medtronic, a giant in the global medical technology industry, acquired the original developer of this technology, CoreValve Inc., in 2009. While Medtronic is headquartered in Dublin, Ireland for tax purposes, its operational roots and major executive offices remain in Minneapolis, Minnesota. The manufacturing of these highly complex components takes place in specialized facilities across the United States, Mexico, and Ireland, reflecting the brand's global supply chain and high-tech engineering requirements.